{"name":"Pentixapharm AG","slug":"pentixapharm-ag","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxOQ2xVMnRmb0RMVVR2eWQ0R3lTUnhmYjdfeWtqQlZxcHlsV1lNajRIdDJkSjRMUnREemhlSEs3OXl3ZW9RYlhxWGx0WEpLSkh2SjIzeHdqdy1qdVl0ZFNtN0NCVkowZHN3bGoxeXphcUlFZkliRjNxVHJfcUVQR05SRmc5MU1lXzRERmZwMEtlUWZrek5CU1dJOENaNlpSbUdkRDdtQVRHUEJZcXFPc0hKOXNoY3BxMlQ1emk5b21n?oc=5","date":"2026-03-31","type":"pipeline","source":"TradingView","summary":"Pentixapharm Holding AG Appoints Erik Merten to the Executive Board - TradingView","headline":"Pentixapharm Holding AG Appoints Erik Merten to the Executive Board","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6gFBVV95cUxNWnpyX0VwVjRIbUNrem1BVTU3a3U4U2hiR3VyeDlWUVJHNDh6X1FQQUpKcFdtSHRLQWI1dkhtQXBHZ2U1MlEzVUdLRGp2OWFCemppQUZlVUR5VlhEbFNob3pPRDNYY3lsdndTMGllNVlnMGNGWXk0aTMzVXBteVhpZ3NTZGZfRVlnWTVPVmdNTVlyTGJLTnI1YUprUnR5cUNCN29QMmN1TzdXZ1pVSXlBOEt0cFdNd3FQZXR5YWVnakNMaHhyc3htd2pRQk5tdE1od3RaVmphTW02cWw4V3hPWWJlakNOV3NTc1E?oc=5","date":"2026-02-25","type":"regulatory","source":"ACCESS Newswire","summary":"Pentixapharm Receives FDA \"Study May Proceed\" Letters for Dual Theranostic INDs in CXCR4-Based Hemato-Oncology Program - ACCESS Newswire","headline":"Pentixapharm Receives FDA \"Study May Proceed\" Letters for Dual Theranostic INDs in CXCR4-Based Hemato-Oncology Program","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5AFBVV95cUxNSTFCUXV0cUFzcVR4c0J5OHdmMkNKM1JpaFlZeHVRaUhaTHpZTXdsTVRnU2dZZGg5OGVyNlFsWTlBUEREUmpmcnBPeGVFQ3lKemZPN01wcDRHUmlLQlJKbk5DSEo3Sk5rcFBPZVBTTFd1NWJydnBYYlhaQWJHbFI1OTlTX3RWMnZrWjVKdUdxMVlqM2R6YmliOGxGWXBadmdWZEpQYjRhdk5kcDVKMUd6NFlzQ1J6RU1EcHMxNG1GcGZ6TC1LRnlmcHZDcmdma0VOcFpldXhuNkJQTXNuRUM0cmZxUEI?oc=5","date":"2026-02-05","type":"trial","source":"ACCESS Newswire","summary":"Pentixapharm Announces Peer-Reviewed Phase 2 Data Back Use of PENTIXAFOR as a Superior Non-invasive PET-Diagnostic for Primary Aldosteronism - ACCESS Newswire","headline":"Pentixapharm Announces Peer-Reviewed Phase 2 Data Back Use of PENTIXAFOR as a Superior Non-invasive PET-Diagnostic for P","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNTDRndUdNZ2dDR210UEZkUWtPNlF2elhVTENQWk0yWG1MZkZoa0xpNkhmN0FhOTF3T3JaUXdkU1dBX2xWcEVMMGtUeVFvZGpkMnBWY29iNkdfcVd3V0h6VFdkSm1VblhSdVFOcGdITm42T09YakpNN25VejZ3TnhVekVpblhaaFFnQnc5NkZsVGdFeVl3cGxXam11Vlhkck96TUdXQnBIYUw?oc=5","date":"2025-10-06","type":"pipeline","source":"Yahoo Finance","summary":"Pentixapharm Highlights Expanding CXCR4 Radiopharmaceutical Platform with New Clinical Findings at EANM 2025 - Yahoo Finance","headline":"Pentixapharm Highlights Expanding CXCR4 Radiopharmaceutical Platform with New Clinical Findings at EANM 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZ0FVX3lxTFBqQUFubmZQeFBXQTdtcWpOdE03Y19HZVg5aWRsMHlhQ0txRHphQm9zWmFIVGhyU3AxajV2dUttQVVYWURLSUYtaVVPaFNQbjB0R0QzR0R4ZGlvcmZtTkl6NFR5WGZWb28?oc=5","date":"2024-10-10","type":"pipeline","source":"TradingView","summary":"Technical Analysis of Pentixapharm Holding AG (XETR:PTP) - TradingView","headline":"Technical Analysis of Pentixapharm Holding AG (XETR:PTP)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxNcU9qUDNlZWh4WUZkMHVIZUZGT21XTjZjek5fZnRsZllQaWhINzhaWXZPV2d2SWZhY1FtU2tfTDNiU2ZtZUtHZG1IOWZ4WDZIRkZLODRPSE5KelFEOUItSUtlSmpwNDI2dUpiM0FOZ0RCbmJISHNtVW81V3dIQjBfZWY3Y2pFYnNmVlA2aDY1NFJ4RkhfMTNOZnBxQjhPMmNjY1kyVGVPUmd0bVV0cnRTU3Q1N0gtd1poSGFER1ozSDFWLUdocGhkOE52U0pVT0NDNkVJQnpLMWw2TE5zcjEzbjlxNFpNVVdhVy1iQw?oc=5","date":"2024-10-07","type":"pipeline","source":"radiologybusiness.com","summary":"Radiopharmaceutical firm Pentixapharm raises $22M through initial public stock offering - radiologybusiness.com","headline":"Radiopharmaceutical firm Pentixapharm raises $22M through initial public stock offering","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWEFVX3lxTE5qVURFNk9kdVRueWdaZy1BMFJLeld2M1YxOXM3TFkySXlIRTg1NDh0Q2VGeXJJcUVTZXdZdHRMQ0xqbUFvNTB6aVdFLVI4VXE1Uk1nTTR1bms?oc=5","date":"2024-10-02","type":"pipeline","source":"TradingView","summary":"PTP Stock Price and Chart — XETR:PTP - TradingView","headline":"PTP Stock Price and Chart — XETR:PTP","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxOUFltOHo2X0VMeVFDaDZBdVVCbi1jQ3pPeHdCN1BpaGdQb2VyUXBodFlmdUp0SlpZbm81emllS2p5NWV5RXRqZzR3Zko3TUVCOXBxUW5Ya2pYb3FCVEVZNlJfS291RFNUZXVkeEJhUFM4aG1yM25VRHMxTFBaZ1JYd1V6OFhZeDNkUkNDcEh2eHltV0FYUlloVy1kSzhOSnV6S1E?oc=5","date":"2024-09-30","type":"deal","source":"pharmaphorum","summary":"Closed and Collaborative: Mergers, acquisitions, and partnerships in July 2024 - pharmaphorum","headline":"Closed and Collaborative: Mergers, acquisitions, and partnerships in July 2024","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}